The expression of IL-6 in the NPC group (51.97 ± 8.02 ng/mL) was significantly higher than that in the control group (4.14 ± 0.03 ng/mL) (p < 0.05). This evidence concerns the gene IL6 and nasopharyngeal carcinoma.